| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |